|
|
|
|
|
|
|
|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
Molecular-Targeted Pharmacotherapy in Myeloma
An enhanced understanding of disease biology offers developers the opportunity to use niche markets such as myeloma as a reduced-risk pathway to the commercialization of molecular-targeted treatments. The identification of prospective clinical, regula
Restless Legs Syndrome - Recognition Lacking Still
Although there are a huge number of individuals who report having the symptoms of RLS, this neurological disorder remains inadequately diagnosed and treated. There are plenty of opportunities in this market for pharmaceutical manufacturers, but raising
Urinary Incontinence: Major Milestones
Urinary incontinence has three main subtypes including stress, urge and mixed, and is estimated to affect 100 million women in the seven major markets. Drug therapy for urinary incontinence has focused on overactive bladder, worth over $1.3 billion in
|
